Telesis Bio Information

Telesis Bio is accelerating the transition from digital biological design to physical experimentation. As AI transforms drug discovery and biological design, researchers can generate more promising sequences and therapeutic candidates than ever before. The next challenge is turning those digital designs into physical DNA quickly enough to test, learn, and iterate. Telesis Bio helps bridge that gap. Through our expertise in DNA biology, enzymatic synthesis, and laboratory automation, we enable researchers to rapidly build accurate, high-quality DNA and mRNA for AI-driven drug discovery, antibody development, protein engineering, and other advanced biological applications. Our technologies help eliminate traditional bottlenecks between design and experiment, enabling faster iteration from computational prediction to physical testing and biological insight. Telesis Bio works with innovators across biotechnology, biopharma, and academia – from emerging companies pioneering new approaches to drug discovery to many of the world’s leading pharmaceutical organizations. Together, we’re helping researchers move faster from digital ideas to physical biology – and from prediction to discovery.